Earnings Call · Q2 FY2024·2024-07-25

Q2 24EPS -0.38%·Rev n/aQ1 24EPS +3.59%·Rev n/aQ4 23EPS +0.72%·Rev n/aQ3 23EPS +2.79%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Liz Shea — Senior Vice President, Investor Relations

Rob Michael — Chief Executive Officer

Jeff Stewart — Executive Vice President, Chief Commercial Officer

Carrie Strom — Senior Vice President, AbbVie and President, Global Allergan Aesthetics

Roopal Thakkar — Executive Vice President, Research and Development, Chief Scientific Officer

Scott Reents — Executive Vice President, Chief Financial Officer

+3.4%1d on move date+3.9% vs SPY3d+3.3%5d+5.2%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access